Denmark's Novozymes to acquire U.S. biotech company

20:47, December 20, 2010      

Email | Print | Subscribe | Comments | Forum 

Danish bio-tech company Novozymes announced Monday that it will purchase American company EMD/Merck Crop BioScience from Merck KGaA for 275 million U.S. dollars.

"We have found in EMD/Merck Crop BioScience a company that has a strong strategic fit with our existing BioAg business. In brief, it has a complementary product range and geographical scope, a strong R&D pipeline, and very talented people," Steen Riisgaard, CEO of Novozymes, said in a press release.

Novozymes' main production is focused on the production of industrial enzymes. EMD/Merck Crop BioScience's products and technologies are used to enhance biological growth using nitrogen biofertilizers.

Source: Xinhua
  • Do you have anything to say?


Special Coverage
  • Focus On China
  • Shanghai World Expo 2010
Major headlines
Editor's Pick
  • Flag-raising ceremony held to mark 11th anniversary of Macao's handover
  • 11th anniversary of Macao's return to motherland celebrated
  • Death toll of Mexico's pipeline explosion rises to 27
  • S. Korea stages firing drill from island shelled by DPRK
  • World's smallest gold teapots unveiled in Beijing
  • Seoul residents protest against war exercise, call for peace
Most Popular
Hot Forum Dicussion